Rab7L1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
RAB7L1 (RAB7 Like 1) is a member of the Rab GTPase family involved in endolysosomal trafficking. It plays critical roles in autophagosome formation, lysosomal function, and protein sorting. Genetic variants in RAB7L1 are associated with increased risk for Parkinson's disease. [@bekris2014]
Overview
RAB7L1 is a member of the Rab GTPase family that regulates vesicular trafficking in the late endosomal and lysosomal pathway. RAB7L1 is involved in autophagosome-lysosome fusion and is implicated in Parkinson's disease pathogenesis through GWAS hits. [@satake2010]
This protein is involved in: [@kuwahara2016]
Vesicular trafficking: Regulates endosomal/lysosomal transport
Autophagy: Controls autophagosome maturation
Protein sorting: Directs cargo to degradative compartments
Therapeutic Modulation: Develop small molecules targeting this axis
Biomarkers: RAB7L1 expression as disease marker
Key Publications
MacLeod DA, et al. RAB7L1 interacts with LRRK2 to modify Parkinson disease risk. Am J Hum Genet. 2013;93(5):840-851.
Bekris LM, et al. LRRK2 and RAB7L1 in Parkinson disease. Neurology. 2014;82(12):1083.
Satake W, et al. Genome-wide association study identifies RAB7L1 as a novel susceptibility gene. Nat Genet. 2010;42(11):973-977.
Kuwahara T, et al. LRRK2 phosphorylates RAB7L1 and regulates autophagosome-lysosome fusion. J Cell Biol. 2016;215(2):187-199.
Background
The study of Rab7L1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.